logo
A Swiss court's decision on use of a pesticide sends a hopeful message to Indian farmers

A Swiss court's decision on use of a pesticide sends a hopeful message to Indian farmers

Scroll.in2 days ago
A Swiss civil court's decision last fortnight to initiate an assessment of evidence regarding the use of the pesticide Polo in a lawsuit against the agrochemical giant Syngenta sends a message to Indian farmers that it is possible to challenge a huge company and hold it accountable, representatives of individuals poisoned by pesticides said.
The cases were brought in 2021 under the Swiss public liability law by the wives of two farmers in Maharashtra's Vidarbha region who died in a wave of 'pesticide poisoning' in 2017 along with a survivor of the poisoning. Polo, manufactured by Syngenta, was widely used in Vidarbha in 2017.
Pesticide poisoning is said to occur when a chemical intended to control insects is ingested or breathed in by a human or absorbed through the skin.
'This indicates that the court in principle considers that Syngenta could be held liable for harm caused by its hazardous products abroad, and paved the way for victims and their families to seek justice before the Swiss court,' said the Pesticide Action Network India in a statement.
The court will treat these three cases separately because different questions regarding evidence may emerge in each of them.
Deadly cocktail
A deadly cocktail of pesticides including Polo is alleged to have caused the deaths of more than 20 farmers in Vidarbha, through contact poisoning and left hundreds affected in 2017 and 2018. The Basel civil court in July 2022, ruled that it had jurisdiction in the case and permitted free legal aid for the complainants, according to a press statement on Monday from PAN India.
The complainants are supported by three organisations: Pesticide Action Network India, Public Eye, which works to make Swiss companies accountable. and the European Centre for Constitutional and Human Rights.
A spokesperson for Public Eye said that the court will now go into the evidence that the parties have submitted during the written submissions and most likely conduct witness hearings and party interviews. The court will see whether it is well enough established that the claimants or their deceased husbands have used the pesticide in question. No new evidence can be submitted at this point.
This phase of the court case is likely to take a while, the Public Eye spokesperson said. If the court decides that this fact is established, the proceedings will continue and the court will decide what the next step should be. If not, the court can reject the case.
The case seeks to hold Syngenta accountable for selling Polo in India, though this is not allowed for sale in the European Union. Polo's active ingredient, diafenthiuron, was banned in the European Union in 2002 to protect the environment and human health.
In 2009, it was taken off the market in Switzerland. In March 2017, diafenthiuron was added to the list of substances that are banned because of their effects on health and the environment, according to Public Eye.
The European Chemicals Agency has said that diafenthiuron is 'toxic if inhaled' and stated that it 'may cause damage to organs through prolonged or repeated exposure'. However, Polo is available freely in countries like India.
Reports by PAN India and Public Eye have documented the large-scale pesticide poisonings in Vidarbha, a European Centre for Constitutional and Human Rights statement said. It said that while Syngenta still denies any responsibility for the events, police records from local authorities in Vidarbha state that 96 cases of poisoning, two of which led to fatalities, were linked to a Syngenta insecticide going by the name of Polo.
This lawsuit was filed after a compulsory mediation procedure in Switzerland had ended without an agreement. It sends a clear message that the Swiss judicial system will deal with cases brought by victims of corporate harm abroad but caused by Swiss companies, according to PAN India.
It added that as the first civil lawsuit from the Global South against an agrochemical company over pesticide poisonings, this case breaks new legal ground.
Earlier, in September 2020, on behalf of 51 affected families, PAN India, the Maharashtra Association of Pesticide Poisoned Persons, Public Eye and the European Centre for Constitutional and Human Rights had filed a complaint against Syngenta with the Organization for Economic Cooperation and Development's Swiss National Contact Point in Bern in September 2020. This is a complaint mechanism under the OECD framework.
While initially the complaint was accepted in December 2020, and four mediation meetings were held with Syngenta in 2021, the proceedings ended in 2022 without a positive outcome or any steps to ensure accountability from the company.
The outcome of the OECD complaint was disappointing for farmers, but this case could set a benchmark in corporate accountability globally. During the mediation, it was emphasised that it was important for the farmers that Syngenta provides remedies to the 51 farmers and farm workers allegedly impacted in Vidarbha in 2017.
However, Syngenta repeatedly asserted that it could not comment on issues that were being dealt with in the proceedings before the Swiss civil court, in particular the question if Polo had caused the poisonings alleged in the complaint.
The European Centre for Constitutional and Human Rights contended that Syngenta's position contradicts the United Nations Guiding Principles on Business and Human Rights, which ensures that businesses are held accountable and also provide access to effective remedy for victims.
This forms an important part of the state's duty to protect against business-related human rights abuses, according to a United Nations High Commission for Human Rights in a 2018 report.
'The group of 51 farmers and their families should not be deprived of their right to access remedy through a non-judicial process simply because another group of victims chose to file a civil lawsuit,' said Marcos Orellana, UN Special Rapporteur on Toxics and Human Rights. 'This is setting a bad precedent that underscores the weaknesses of national contact points for the OECD Guidelines'.
In addition the complaint had demanded that the provisions of the International Code of Conduct on Pesticide Management be implemented by Syngenta to prevent future cases of poisoning in India. Even this demand was not conceded.
The European Centre for Constitutional and Human Rights stated that the code required that companies avoid selling hazardous products such as Polo, whose handling and application require the use of personal protective equipment that is uncomfortable, expensive or not readily available to small-scale users and farm workers in countries with hot climates such as India.
One of the problems that emerged in the increased pesticide poisoning cases in 2017 and 2018 was that few farmers wore any sort of protective clothing. It was only in 2018 that some sort of protocol to use pesticides and treat the severe cases was established.
Deaths confirmed
In an Right to Information application filed by this correspondent in 2017-'18, the police records confirmed 22 deaths and 349 affected by pesticide poisoning in Yavatmal district alone in 2017 and 20-odd more deaths in other districts of Vidarbha region.
Only in five deaths in Yavatmal did the police file cases against pesticide dealers under section 304(a) of the Indian Penal Code (causing death by negligence and the Insecticide Act).
Most of those who died had used monocrotophos as one of the chemicals they sprayed and a mixture of toxic pesticides. The first farmer who was killed, Devidas Madavi, used Profex Super, a combination of profenofos and cypermethrin, that other farmers also did. At least 80 of those affected and who survived, reported using Polo, according to police records, sometimes along with other chemicals.
A state government Special Investigation Team report said that in 2016-'17, treatment for pesticide poisoning had been sought by 434 patients. In 2017-'18. the number doubled to 886. There is continuing cause for concern as pesticides like Polo continue to be used for cotton, posing a grave threat to farmers and the environment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How did US trader Jane Street allegedly cheat Indian markets to make ₹36,500 crore
How did US trader Jane Street allegedly cheat Indian markets to make ₹36,500 crore

Hindustan Times

time18 minutes ago

  • Hindustan Times

How did US trader Jane Street allegedly cheat Indian markets to make ₹36,500 crore

Securities and Exchange Board of India (SEBI), has taken unprecedented action against Jane Street, one of the world's largest quantitative trading firms. The regulator has banned the US-based company and its affiliated entities from the Indian securities market and ordered them to return ₹4,843 crore in alleged unlawful profits. Jane Street has denied the accusations. The US-based company, Jane Street, has been banned from the Indian securities market by SEBI.(Reuters File) What is Jane Street and how big is it? Jane Street is a global proprietary trading firm founded in 2000. It has more than 3,000 employees and offices across the US, Europe, and Asia. The firm operates in 45 countries. Its footprint in Asia is growing rapidly, especially in Hong Kong. According to a Reuters report, Jane Street had an annual revenue of $20.5 billion last year. Jane Street's operations in India According to SEBI, Jane Street's trading activity in India has been substantial. Between January 2023 and March 2025, it earned nearly $5 billion (about ₹36,671 crore) through index options trading. Out of this, ₹4,843 crore is now under investigation as unlawful gains. Jane Street first drew wider attention in India in 2023 when it sued a rival hedge fund, Millennium Management, in a US court. The case revealed that Jane Street had developed a profitable India-based options trading strategy, which earned it $1 billion in 2023 alone. The two firms settled the dispute later that year. Apart from that, media reports in April 2024 raised concerns about Jane Street's use of proprietary trading strategies in India. After which, the regulatory body examined the firm's trading behaviour, and subsequently issued a detailed interim order in July 2025. What did SEBI investigation revealed? SEBI's interim order outlines serious allegations. Jane Street is accused of manipulating index levels—especially the Nifty and Bank Nifty—on 21 different expiry days between January 2023 and May 2025, reported news agency PTI. In SEBI's report, two main strategies were flagged: Morning pump, afternoon dump: Jane Street allegedly bought large quantities of Bank Nifty stocks and futures early in the day, pushing the index higher. Later, it sold off these positions aggressively, depressing the index by closing time. According to the SEBI, this strategy gave a false impression of market strength, misleading other traders—particularly retail investors—into believing the index was genuinely rising. Expiry day index manipulation: The firm also reportedly executed large, targeted trades in the final hours of expiry days to influence index closing levels, thus affecting options pricing. These actions allowed Jane Street to make large profits in the options market, while the smaller losses it took in cash and futures trades were more than offset by gains from index options. SEBI's findings show Jane Street made: ₹ 44,358 crore in index options gains 44,358 crore in index options gains ₹ 7,208 crore in losses from stock futures 7,208 crore in losses from stock futures ₹ 191 crore in losses from index futures 191 crore in losses from index futures ₹ 288 crore in cash market losses This resulted in a net profit of ₹36,671 crore, out of which ₹4,843 crore is considered illegal by the regulator and has been ordered to be disgorged. As a result, SEBI has barred four Jane Street-linked entities from accessing the securities market: JSI Investments JSI2 Investments Pvt Ltd Jane Street Singapore Pte Ltd Jane Street Asia Trading Calling Jane Street's actions a 'clear disregard' of regulatory warnings, SEBI has prohibited the Group from buying, selling, or dealing in securities, either directly or indirectly, until the manipulation probe concludes. Banks holding accounts of these entities have been told to freeze withdrawals unless SEBI allows it. SEBI further noted that the Jane Street Group kept doing questionable trades, especially near market closing on expiry days. It made large and aggressive moves to unfairly move the index, even after getting a warning in February and assuring the NSE that it would stop such actions. In its order, SEBI said: 'Such egregious behaviour, in clear disregard/ defiance of the explicit advisory issued to them by NSE in February 2025, amply demonstrates that unlike the vast majority of Foreign Portfolio Investors and other market participants, JS Group is not a good faith actor that can be, or deserves to be, trusted.' (With Reuters, PTI inputs)

Cities that care: Incorporate caregiving infrastructure into urban planning
Cities that care: Incorporate caregiving infrastructure into urban planning

Mint

time26 minutes ago

  • Mint

Cities that care: Incorporate caregiving infrastructure into urban planning

Everyone needs care, but the care needs of some are particularly urgent, and this population is steadily rising. The elderly are projected to reach 158 million in 2025 (UNFPA). There are 158 million children under six (UNICEF), and about 40-90 million people with disabilities (World Bank). The care of all these segments requires supportive physical and human infrastructure, as it depends on human skill and care-friendly environments at home and outside. These services can help families secure supplementary care when needed, especially as women continue to be the primary caregivers (Time Use Survey 2025). Similarly, physical infrastructure for care affects how easily primary caregivers can manage their daily responsibilities for their dependents while participating in economic activities. Also Read: Wholesome care: All hospitals should help their patients make living wills Let us choose the latter against the backdrop of childcare and women's increasing participation in the labour force, which rose from 23% in 2018 to 37% in 2023. Since 2019, women's care work has remained over 300 minutes daily, while paid work increased by six minutes. Yet, India's public and workplace infrastructure continues to take 'care" for granted, assuming that the design of public spaces has no impact on it. Unlike roads, railways and power grids designed to facilitate movement and commerce, the care infrastructure, including lactation rooms, changing stations and creches, remain inadequate or completely lacking in modern cities. In metro stations, public parks, courts, police stations, marketplaces and most offices, this infrastructure is either non-existent or inadequate. Navigating streets, buses, railways and footpaths with strollers can be exhausting and impossible, with the hardships compounded for women with disabilities. Despite accessibility features, the National Building Code lacks lactation rooms, rendering public infrastructure inconvenient and exclusionary to breastfeeding mothers returning to work. Without supportive environments, World Health Organization (WHO) guidelines on breastfeeding are difficult to follow for mothers returning to work. As high as 81% of mothers said they were uncomfortable feeding their children in public due to the lack of proper breastfeeding places. Only 6% of Indian mothers feel comfortable breastfeeding in public despite legal protections. Without safe and hygienic spaces, many are forced to skip feedings or use storage closets and public toilets, which are neither safe nor dignified options. An IIT Delhi study found that young mothers with infants are the least mobile in India. These design gaps subtly shape who feels welcome in public spaces and potentially push many women out of the workforce after childbirth, thereby weakening India's economic engine. Also Read: Gender and Age: We need a female perspective on ageing populations India must embed care infrastructure into city planning, workplace design and transportation networks. This requires institutionalizing a future-ready national care policy encompassing three key areas: First, the National Guidelines that mandate lactation centres in health facilities must be extended to all public spaces, with standardized infrastructure like crèches, changing stations, incorporating safe and accessible design. This should be integrated into the National Building Code 2016. Second, investments in human care infrastructure by professionalizing caregiving services and supporting women-led care enterprises. Third, anchor these through a national care policy, linking care to labour, urban development and health, with adequate budgets and workplace protections. These should encourage affordable and high-quality care services from the private sector. Public campaigns normalizing male caregiving roles and reducing stigma around breastfeeding can strengthen care as a pillar of social equity and economic productivity. Globally, countries are reimagining care and its supporting infrastructure. Spain and Colombia are integrating care into city planning. Singapore offers portable lactation pods that can be located and accessed through an app. The US has a legal requirement for lactation rooms, with reasonable lactation breaks for breastfeeding employees. Also Read: India's growth and urban planning: On different planets The UK offers up to £2,000 per child annually to help cover registered childcare expenses. Argentina offers childcare allowances for unemployed or informal workers and childcare in the workplace. Germany offers care insurance to cover the costs of long-term care services. India has the opportunity to craft its unique state-led model rooted in scale, local context and inclusion of families from diverse socio-economic backgrounds. This will allow us to shape a future of work where women are no longer forced to choose between caregiving and economic participation, but are supported in doing both with dignity and freedom. As Nancy Folbre reminds us, 'The work of care is not just an obligation, it is a form of social wealth creation." It is time we designed systems that recognize and reward this critical labour as foundational to a just and thriving economy. The authors are, respectively, associate partner and global lead, gender equality, disability and social inclusion (GEDSI) practice; and senior manager, GEDSI, MicroSave Consulting.

'None of them are really doctors': Liver Doc takes on Vidit Gujrathi on X
'None of them are really doctors': Liver Doc takes on Vidit Gujrathi on X

Business Standard

time31 minutes ago

  • Business Standard

'None of them are really doctors': Liver Doc takes on Vidit Gujrathi on X

Indian Chess Grandmaster Vidit Gujrathi finds himself at the centre of a social media storm after a seemingly innocent Doctor's Day post triggered a fiery exchange with anti-ayurveda crusader Dr. Cyriac Abby Philips, better known online as the 'Liver Doc.' What started as a heartfelt tribute — a family selfie captioned 'Happy Doctor's Day to my entire family' — quickly spiralled into controversy. When a user asked about his family's medical background, Vidit replied that his father is an Ayurvedic migraine specialist, his wife holds an MD in homeopathy, his mother practices cosmetology, and his sister is a physiotherapist. But the Liver Doc wasted no time in firing back, bluntly declaring, 'I'm sorry, but none of them are really doctors,' dismissing the qualifications as unscientific or pseudoscientific. The remark drew backlash — and Vidit, usually reserved, hit back sharply: 'Stay in your lane and try being useful.' The digital clash has since stirred debate across the platform, pitting advocates of traditional medicine against voices from modern science, with Gujrathi's post becoming the unexpected battleground. A user replied to Vidit, saying 'you are an influential figure, so you have the responsibility not to spread misinformation. Doctor's day on July 1st is celebrated for Doctors of medical science. Not homeopaths, not ayurvedics or any other professions that have nothing to do with medicine. So educate yourself and be responsible instead of feeling personally attacked by someone for just pointing out that they are not indeed real doctors.' For the past five years, Dr. Cyriac Abby Philips — a hepatologist and clinical researcher from Kerala — has been on a mission: treating patients harmed by the misuse of alternative medicines. Since 2019, he's taken that fight online, using his Twitter handle @theliverdr to launch sharp, data-driven takedowns of Ayurveda, Homeopathy, Siddha, and Unani systems. His posts often go viral, earning him both praise from science advocates and criticism from supporters of traditional medicine — making him one of the most polarising voices in India's healthcare debate. Hot battle: Modern medicine Vs Ayurveda The clash between modern medicine and traditional systems like Ayurveda has been brewing for years — and this latest exchange has only poured fuel on the fire. As his back-and-forth with Vidit Gujrathi escalated, Dr. Cyriac Abby Philips doubled down on his stance, writing on X: 'Your statement on Doctors' Day claiming an Ayurveda practitioner, homeopath, cosmetologist and physiotherapist were doctors is wrong, and I stand by my words.' 'Doctors' Day in India marks both the birth and death anniversary of Dr. Bidhan Chandra Roy, one of India's most revered physicians and a key figure in shaping the healthcare system,' he added. 'Ayurveda, Homeopathy, Cosmetology or Physiotherapy are not realistic clinical medicine or and their practitioners are not clinical physicians.' Supporters of modern medicine quickly rallied behind him. One user praised his boldness: 'Salute to you, Doctor, for fearlessly exposing the fraudulent practices carried out in the name of medicine. Your courage and integrity are a true service to humanity.' One more went, 'I have the deepest respect and awe for ppl who are good at chess bcoz I'm not. But sorry, Ayurveda Homoeopathy etc are quackery and dangerous. People are often healed there because many illnesses are self limiting & also due to placebo effect.' The defenders of Ayurveda didn't hold back either. One user confronted the Liver Doc, saying 'Though I respect your contribution to society but who are you talking negative about Ayurveda ? This is not so mature of you Doctor. There is a whole government department called AYUSH propagating Ayurveda. The Ayurveda industry is a 20 billion USD market . Ayurveda was born 5000 years ago. The user continued, 'There is Hindu god called Dhawantri of Ayurveda. Doctors basically are called healers. So anybody helping in healing gets that badge. I don't know about other branches but Ayurveda, Homeopathy & physiotherapy are definitely healers.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store